Terumo Medical Corporation Executive and Leadership Team

John Pinto, the Chief Financial Officer at Terumo Medical Corporation, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the manufacturing of hollow-fiber technology and blood-management systems. This leadership role involves managing complex budgetary requirements across North American operations to drive sustainable growth. By optimizing resource distribution, John Pinto directly impacts the ability of the company to invest in research and development for clinical thermometers. Ultimately, Pinto secures long-term financial stability through disciplined risk management and strategic investment oversight, ensuring the enterprise maintains a competitive edge in the medical device sector while delivering consistent value to stakeholders and supporting the broader mission of enhancing patient care through technological excellence.

Kota Yamamura, the President at Terumo Medical Corporation, directs the overarching corporate strategy and operational execution for the organization. Overseeing the integration of advanced manufacturing processes, the President ensures alignment between product development and market demand for endovascular therapy solutions. This leadership role involves coordinating with global stakeholders to expand the reach of medical products within the healthcare industry. By fostering a culture of innovation and operational efficiency, Kota Yamamura directly impacts the market position of the company. Ultimately, Yamamura drives the expansion of clinical capabilities, ensuring that the organization remains at the forefront of medical technology while maintaining high standards of quality and safety across all product lines, thereby solidifying the reputation of the firm as a leader in the medical manufacturing landscape.

Keiichi Amatatsu, the President at Terumo Medical Corporation, directs the strategic initiatives focused on regional market penetration and operational excellence. Overseeing the supply chain logistics for blood-management systems, the President ensures seamless delivery of critical medical tools to healthcare providers. This leadership role involves managing cross-functional teams to optimize the production of clinical thermometers and other essential devices. By streamlining internal workflows, Keiichi Amatatsu directly impacts the operational agility of the company in response to shifting healthcare needs. Ultimately, Amatatsu strengthens the presence of the organization in competitive markets, ensuring that manufacturing output meets the highest regulatory requirements while simultaneously fostering growth through targeted business development efforts that align with the long-term vision of the firm to improve patient outcomes globally.

Michael Martinelli, the Senior VP, Medcal Affairs & Chief Medical Officer at Terumo Medical Corporation, directs all clinical research and medical safety protocols. Overseeing the scientific validation of endovascular therapy solutions, the Senior VP, Medcal Affairs & Chief Medical Officer ensures that all products meet rigorous clinical standards before reaching the market. This leadership role involves collaborating with medical professionals to gather insights that inform the development of next-generation hollow-fiber technology. By bridging the gap between clinical practice and product engineering, Michael Martinelli directly impacts the efficacy and safety of the medical devices produced. Ultimately, Martinelli maintains the integrity of the clinical programs, ensuring that the company upholds its commitment to patient health through evidence-based innovation and continuous improvement of medical product performance across diverse therapeutic areas.